Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2018 3
2019 7
2020 1
2021 5
2022 4
2023 7
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Emerging drugs for the treatment of Myelofibrosis.
Shreenivas A, Mascarenhas J. Shreenivas A, et al. Expert Opin Emerg Drugs. 2018 Mar;23(1):37-49. doi: 10.1080/14728214.2018.1445718. Epub 2018 Mar 6. Expert Opin Emerg Drugs. 2018. PMID: 29480036 Review.
Reply to S. Cavalieri et al.
Limaye S, Kumar P, Datar R, Shreenivas A. Limaye S, et al. Among authors: shreenivas a. JCO Precis Oncol. 2021 Nov;5:1528-1529. doi: 10.1200/PO.21.00353. JCO Precis Oncol. 2021. PMID: 34994641 No abstract available.
Carcinoma of unknown primary: Molecular tumor board-based therapy.
Shreenivas AV, Kato S, Hu J, Skefos C, Sicklick J, Kurzrock R. Shreenivas AV, et al. CA Cancer J Clin. 2022 Nov;72(6):510-523. doi: 10.3322/caac.21748. Epub 2022 Aug 25. CA Cancer J Clin. 2022. PMID: 36006378 Free PMC article. No abstract available.
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Tahir SK, Calvo E, Carneiro BA, Yuda J, Shreenivas A, Jongen-Lavrencic M, Gort E, Ishizawa K, Morillo D, Biesdorf C, Smith M, Cheng D, Motwani M, Sharon D, Uziel T, Modi DA, Buchanan FG, Morgan-Lappe S, Medeiros BC, Phillips DC. Tahir SK, et al. Among authors: shreenivas a. Blood. 2023 Apr 27;141(17):2114-2126. doi: 10.1182/blood.2022017333. Blood. 2023. PMID: 36720090 Free PMC article.
Genomic profiling and precision medicine in complex ameloblastoma.
Gates JC, Clark AP, Cherkas E, Shreenivas AV, Kraus D, Danzinger N, Huang RSP, Johnson J, Ross JS. Gates JC, et al. Among authors: shreenivas av. Head Neck. 2023 Apr;45(4):816-826. doi: 10.1002/hed.27294. Epub 2023 Jan 16. Head Neck. 2023. PMID: 36645099
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N. Inamoto Y, et al. Among authors: shreenivas a. Biol Blood Marrow Transplant. 2019 May;25(5):e145-e154. doi: 10.1016/j.bbmt.2018.11.033. Epub 2018 Dec 3. Biol Blood Marrow Transplant. 2019. PMID: 30521975 Free PMC article. Review.
35 results